GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a substantial shift in how we approach type 2 diabetes . These new medications function to stimulating the body’s own GLP-1 process, https://checkbookmarks.com/story7443588/glp-1-a-significant-breakthrough-in-blood-sugar-management